Leap Therapeutics Secures $58.88 Million for Cryptocurrency-Backed Treasury Strategy

Biotechnology firm Leap Therapeutics (Nasdaq: LPTX) has secured a significant funding boost of $58.88 million through a private investment in public equity (PIPE) transaction, paving the way for the establishment of a crypto-focused treasury strategy. The capital raise was spearheaded by Winklevoss Capital, the family office of cryptocurrency exchange Gemini’s Tyler and Cameron Winklevoss. The firm will provide both financial backing and strategic expertise as Leap implements its innovative approach to managing digital assets.